ArticleUpdates in surgery2026
Gasless robotic transaxillary hemithyroidectomy using the da Vinci single-port surgical system: first experience from Europe.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gasless transaxillary robotic thyroidectomy eliminates anterior neck scarring while providing excellent cosmetic outcomes. The da Vince SP system employs a single robotic arm to deliver its full suite of tools: a 0° high-definition, three-dimensional, multi-jointed endoscope and three articulating EndoWrist instruments. We report the first two European cases of SP-assisted gasless hemithyroidectomy through a single transaxillary approach. Both hemithyroidectomies were completed safely without intraoperative complications, and both patients were discharged on postoperative day 2. Our initial experience confirms that SP-assisted gasless transaxillary thyroidectomy is technically feasible, safe, and yields excellent cosmetic results. Broader adoption and larger studies are required to evaluate its clinical advantages and limitations further.
Indexed as
Identifiers
41874915What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.